Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Researchers created a cell line to study hair growth and found specific genes affected by dihydrotestosterone.

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Testosterone may slow down wound healing and increase inflammation.

Substance from human umbilical cord blood cells promotes hair growth.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

Scalp rolling might help regrow hair in people with a hair loss condition called Alopecia Areata.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hair restoration surgery can effectively increase pubic hair density, with patient satisfaction and natural results largely depending on the chosen hair pattern and graft design.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

The study created a new hair loss treatment paste that regrows hair faster and with fewer side effects than minoxidil alone.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

Metformin helps manage weight, blood pressure, and hormonal imbalances in PCOS patients.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Acne affects most teenagers and can continue into adulthood, with various treatments available that show improvement but have concerns like antibiotic resistance and side effects.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.